Oxidative stress and inflammation are major contributors to accelerated age-related relative telomere length (RTL) shortening. Both conditions are strongly linked to leptin and adiponectin, the most prominent adipocyte-derived protein hormones. As high leptin levels and low levels of adiponectin have been implicated in inflammation, one expects adiponectin to be positively associated with RTL while leptin should be negatively associated. Within the ENGAGE consortium, we investigated the association of RTL with adiponectin and leptin in seven independent cohorts with a total of 11,448 participants. We performed partial correlation analysis on Z-transformed RTL and LN-transformed leptin/adiponectin, adjusting for age and sex. In extended models we adjusted for body mass index (BMI) and C-reactive protein (CRP). Adiponectin showed a borderline significant association with RTL. This appeared to be determined by a single study and when the outlier study was removed, this association disappeared. The association between RTL and leptin was highly significant (r = −0.05; p = 1.81 × 10−7). Additional adjustment for BMI or CRP did not change the results. Sex-stratified analysis revealed no difference between men and women. Our study suggests that high leptin levels are associated with short RTL.
This is a preview of subscription content, log in to check access
The study was supported by grants from The Netherlands Organisation for Scientific Research (NWO), Erasmus MC, the Centre for Medical Systems Biology (CMSB), The European Community’s Seventh Framework Programme (FP7/2007–2013), ENGAGE Consortium, Grant agreement HEALTH-F4-2007- 201413 and Netherlands Consortium for Healthy Ageing (Grant 050-060-810). We are grateful to all general practitioners for their contributions, to Petra Veraart for her help in genealogy, Jeannette Vergeer for the supervision of the laboratory work and Peter Snijders for his help in data collection.
The KORA studies were financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany and supported by Grants from the German Federal Ministry of Education and Research (BMBF). Part of this work was financed by the German National Genome Research Network (NGFN; NGFNPlus, project number 01GS0834) and supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. Telomere assays were funded by the ENGAGE consortium. This study was supported in part by a Grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The measurement of adiponectin in KORA F3 was partially funded by the “Tiroler Wissenschaftsfonds” (Project UNI-0407/29) and by the “Genomics of Lipid-associated Disorders—GOLD” of the “Austrian Genome Research Programme GEN-AU” to F. Kronenberg. We appreciate the technical assistance of Barbara Luhan.
We thank all participants of the Leiden Longevity Study. The research leading to these results has received funding from the European Union’s Seventh Framework Programme (FP7/2007–2011) under Grant agreement no 259679. This study was supported by a Grant from the Innovation-Oriented Research Program on Genomics (SenterNovem IGE05007), the Centre for Medical Systems Biology, and the Netherlands Consortium for Healthy Ageing (Grant 050-060-810), all in the framework of the Netherlands Genomics Initiative, Netherlands Organization for Scientific Research (NWO), and by Unilever Colworth.
The study was funded by the Wellcome Trust; European Community’s Seventh Framework Programme (FP7/2007–2013), ENGAGE project grant agreement (HEALTH-F4-2007-201413). The study also receives support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. TDS is an NIHR senior Investigator and is holder of an ERC Advanced Principal Investigator award. Genotyping was performed by The Wellcome Trust Sanger Institute, support of the National Eye Institute via an NIH/CIDR genotyping project.
The measurement of telomere length in the SAPHIR-study was funded by the Austrian Heart Fund to F. Kronenberg. The SAPHIR-study was partially supported by a grant from the Kamillo-Eisner Stiftung, Salzburger Forschungsgesellschaft, Oesterreichische Nationalbank (OeNB Nr. 13339) and the Paracelsus Medical University (FFF-PMU Nr. E-09/09/055-PAU) to B. Paulweber.
The study was supported by Helsinki University Hospital Research Funds, grants from Novo Nordisk, Diabetes Research Foundation, Finnish Foundation for Cardiovascular Research, Biomedicum Helsinki, Jalmari and Rauha Ahokas Foundation, and the Academy of Finland Centre of Excellence in Complex Disease Genetics. Data collection in FinnTwin16 and FinnTwin12 were supported by the National Institute of Alcohol Abuse and Alcoholism (Grants AA-12502 and AA-09203 to Richard J Rose), and the Academy of Finland (grants 44069, 205585, 118555, 141054 to JK) and by the EU funded projects TORNADO (FP7-KBBE-22270) and ENGAGE (FP7-HEALTH-F4-2007).
Enriori PJ, et al. Leptin resistance and obesity. Obesity (Silver Spring). 2006;14(Suppl 5):254S–8S.CrossRefGoogle Scholar
Blackburn EH, Gall JG. A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol. 1978;120(1):33–53.PubMedCrossRefGoogle Scholar
Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, tetrahymena and yeast to human cancer and aging. Nat Med. 2006;12(10):1133–8.PubMedCrossRefGoogle Scholar
Halvorsen TL, et al. Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol. 2000;166(1):103–9.PubMedCrossRefGoogle Scholar
Kurz DJ, et al. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci. 2004;117(Pt 11):2417–26.PubMedCrossRefGoogle Scholar
von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27(7):339–44.CrossRefGoogle Scholar
von Zglinicki T, et al. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res. 1995;220(1):186–93.CrossRefGoogle Scholar
Brouilette S, et al. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol. 2003;23(5):842–6.PubMedCrossRefGoogle Scholar
Brouilette SW, et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet. 2007;369(9556):107–14.PubMedCrossRefGoogle Scholar
Fitzpatrick AL, et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 2007;165(1):14–21.PubMedCrossRefGoogle Scholar
Kalantar-Zadeh K, et al. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol. 2006;26(2):118–33.PubMedCrossRefGoogle Scholar
Aviv A, et al. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J Clin Endocrinol Metab. 2006;91(2):635–40.PubMedCrossRefGoogle Scholar
Diaz VA, et al. Telomere length and adiposity in a racially diverse sample. Int J Obes (Lond). 2010;34(2):261–5.CrossRefGoogle Scholar
Njajou OT, et al. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond). 2011;36:1176.CrossRefGoogle Scholar
Njajou OT, et al. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond). 2012;36(9):1176–9.CrossRefGoogle Scholar
Zhu H, et al. Leukocyte telomere length in healthy Caucasian and African-American adolescents: relationships with race, sex, adiposity, adipokines, and physical activity. J Pediatr. 2011;158(2):215–20.PubMedCrossRefPubMedCentralGoogle Scholar
Al-Attas OS, et al. Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin. Eur J Endocrinol. 2010;163(4):601–7.PubMedCrossRefPubMedCentralGoogle Scholar
Aulchenko YS, et al. Linkage disequilibrium in young genetically isolated Dutch population. Eur J Hum Genet. 2004;12(7):527–34.PubMedCrossRefGoogle Scholar
Pardo LM, et al. The effect of genetic drift in a young genetically isolated population. Ann Hum Genet. 2005;69(Pt 3):288–95.PubMedCrossRefGoogle Scholar
Wichmann HE, et al. KORA-gen–resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen. 2005;67(Suppl 1):S26–30.PubMedCrossRefGoogle Scholar
Schoenmaker M, et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet. 2006;14(1):79–84.PubMedGoogle Scholar
Beekman M, et al. Chromosome 4q25, microsomal transfer protein gene, and human longevity: novel data and a meta-analysis of association studies. J Gerontol A Biol Sci Med Sci. 2006;61(4):355–62.PubMedCrossRefGoogle Scholar
Moayyeri A et al. Cohort profile: TwinsUK and healthy ageing twin study. Int J Epidemiol. 2012.Google Scholar
Heid IM, et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes. 2006;55(2):375–84.PubMedCrossRefGoogle Scholar
Maiolino G, et al. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab. 2008;93(9):3333–40.PubMedCrossRefGoogle Scholar
Menon V, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(9):2599–606.PubMedCrossRefGoogle Scholar
Pilz S, et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab. 2006;91(11):4277–86.PubMedCrossRefGoogle Scholar
Jorsal A, et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int. 2008;74(5):649–54.PubMedCrossRefGoogle Scholar
Kollerits B, et al. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int. 2007;71(12):1279–86.PubMedCrossRefGoogle Scholar
Saraheimo M, et al. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care. 2008;31(6):1165–9.PubMedCrossRefGoogle Scholar
van Himbergen TM, et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the framingham heart study. Arch Neurol. 2012;69:594.PubMedCrossRefGoogle Scholar
Li S, et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179–88.PubMedCrossRefGoogle Scholar
Costacou T, et al. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh epidemiology of diabetes complications study. Diabetologia. 2005;48(1):41–8.PubMedCrossRefGoogle Scholar
Pischon T, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291(14):1730–7.PubMedCrossRefGoogle Scholar
Schulze MB, et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005;54(2):534–9.PubMedCrossRefGoogle Scholar
Arita Y, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79–83.PubMedCrossRefGoogle Scholar
Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996;271(18):10697–703.PubMedCrossRefGoogle Scholar
Nordfjall K, et al. Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring). 2008;16(12):2682–9.CrossRefGoogle Scholar
Horn T, Robertson BC, Gemmell NJ. The use of telomere length in ecology and evolutionary biology. Heredity (Edinb). 2010;105(6):497–506.CrossRefGoogle Scholar
Tsao TS, et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem. 2003;278(50):50810–7.PubMedCrossRefGoogle Scholar
Waki H, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003;278(41):40352–63.PubMedCrossRefGoogle Scholar
Wang Y, et al. Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics. 2004;4(12):3933–42.PubMedCrossRefGoogle Scholar
Hara K, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006;29(6):1357–62.PubMedCrossRefGoogle Scholar
Komura N, et al. Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J. 2008;72(1):23–8.PubMedCrossRefGoogle Scholar